The case for alpha 1-adrenoceptor antagonists as first-line antihypertensive agents.
University Department of Medicine and Therapeutics, Stobhill General Hospital, Glasgow, UK.
H L
HL
Elliott
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D013575:Syncope / Q000139:chemically induced; D014655:Vascular Resistance / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents